NV

Neha Vinish Sheth

Active Director Director DIN 10727731
DIN 10727731 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Neha Vinish Sheth

Data last updated:

Neha Vinish Sheth is a Director at Parry Pharma Private Limited (since 2024). The company operates in Pharma. Parry Pharma Private Limited reported revenue of ₹2.83 Cr (FY 2025).

DIN 10727731
Primary Designation Director
Industry Pharma
First Appointment 05 Aug 2024
Oldest Company Age 33 yrs
Largest company Parry Pharma Private Limited · ₹2.83 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parry Pharma Private Limited U24231GJ1992PTC018540
Director05 Aug 20241992₹2.83 Cr (FY 2025)Active

Board colleagues of Neha Vinish Sheth

Directorship timeline

Open interactive timeline →
Parry Pharma Private Limited
Premium access

Shareholding and investment profile for Neha Vinish Sheth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neha Vinish Sheth

Neha Vinish Sheth currently holds 1 directorship: Parry Pharma Private Limited (Director, since 05 Aug 2024, revenue ₹2.83 Cr (FY 2025)).

Neha Vinish Sheth was first appointed on 05 Aug 2024 as Director at Parry Pharma Private Limited.

The current boards of Neha Vinish Sheth's companies include Nitin Shantilal Bhagat (Parry Pharma Private Limited), Nupur Nitinbhai Bhagat (Parry Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available